Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of Inhaled Salbutamol in the Management of Transient Tachypnea of the Newborn(TTN)

NCT07350421 is registered in ClinicalTrials.gov with Latakia University as lead sponsor.

NCT NCT07350421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07350421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of Inhaled Salbutamol in the Management of Transient Tachypnea of the Newborn(TTN)
Lead sponsor
Latakia University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
March 1, 2028
Enrollment
1 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ttn